Aurora Pharmaceutical announces the availability of EquiCoxib, the FDA-approved generic equivalent of Equioxx® (firocoxib), a non-steroidal anti-inflammatory drug (NSAID) used for pain and inflammation associated with osteoarthritis. Designed with ease of use in mind, EquiCoxib offers veterinarians and horse owners a simple and effective solution for the roller-coaster effect of pain and pain relief that can occur with other products which might require multiple daily dosing.
EquiCoxib has received full approval from the U.S. Food and Drug Administration (FDA) as a generic equivalent to Equioxx® (firocoxib). This approval signifies that EquiCoxib meets the rigorous safety and efficacy standards set by the FDA, providing a reliable and cost-effective alternative to the brand-name product.
One of the standout features of EquiCoxib is its liquid formulation. With a concentrated solution, it is a great alternative to what had previously been available to the marketplace, giving horse owners and veterinarians a choice when it comes to treating pain.
